Regulated Proteolysis of Xom Mediates Dorsoventral Pattern Formation during Early Xenopus Development  by Zhu, Zhenglun & Kirschner, Marc
Developmental Cell, Vol. 3, 557–568, October, 2002, Copyright 2002 by Cell Press
Regulated Proteolysis of Xom Mediates
Dorsoventral Pattern Formation
during Early Xenopus Development
To ask more generally whether proteolysis plays a
role in early pattern formation after the initial dorsoven-
tral axis determination process, we developed a screen
for proteins that are differentially degraded during devel-
opment. We found that Xom (also known as Vent-2, Vox,
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Brigham and Women’s Hospital homeobox transcription factor in the BMP4 signaling
Boston, Massachusetts 02115 pathway, is degraded in an embryonic stage-specific
manner. Xom exerts its ventralizing effect by binding to
the BIE motif of dorsal-specific genes such as Goose-
Summary coid, acting as a direct transcriptional repressor (Trin-
dade et al., 1999). Previous studies showed that the
To identify a regulatory role for proteolysis during early spatial expression pattern of Xom RNA is similar to that
Xenopus development, we developed a biochemical of BMP4. Prior to gastrulation (stage 9), Xom is ex-
screen for proteins that are degraded in an embryonic pressed throughout the embryo (Ladher et al., 1996;
stage-specific manner. We found that Xom, a homeo- Schmidt et al., 1996). During early gastrulation (stage
box transcriptional repressor of dorsal-specific genes, 10.5), Xom RNA is located at the ventral lateral regions
was degraded precipitously during early gastrulation. of the embryo but is absent from the Spemann organizer
Xom degradation is regulated by phosphorylation at (Ladher et al., 1996; Onichtchouk et al., 1998; Schmidt
a GSK3-like consensus site and is most likely mediated et al., 1996). Ectopic expression of Xom on the dorsal
by the SCF--TRCP complex. Expression of nonde- side ventralizes the embryo, which resembles the effect
gradable Xom represses transcription of dorsal genes of BMP4 overexpression (Ladher et al., 1996). Moreover,
much more effectively than wild-type Xom and results the dorsalizing phenotype resulting from ectopic ex-
in a more strongly ventralized phenotype. We propose pression of the dominant-negative BMP receptor can
that regulated Xom proteolysis plays an essential role
be rescued by ectopic expression of Xom (Onichtchouk
in the establishment of the dorsoventral axis, by con-
et al., 1998).
verting a gradient in BMP abundance into a sharp dor-
Our current experiments show that the same ubi-
soventral pattern.
quitination pathway that mediates the degradation of
-catenin is also involved in the degradation of Xom.Introduction
As in -catenin, Xom degradation is controlled by the
phosphorylation status of the GSK3-like consensus siteRegulated proteolysis mediated by ubiquitin plays an
in the Xom destruction motif. Xom degradation is acti-essential role in biological processes such as the cell
vated abruptly at gastrulation. Nondegradable Xom iscycle, transcription, antigen presentation, inflammation,
more active than wild-type in blocking the transcriptionand repair of DNA damage (Hershko and Ciechanover,
of the Goosecoid promoter. Ectopic expression of non-1998; Hochstrasser, 1996; Peters et al., 1998). Although
degradable mutants of Xom on the dorsal side resultseach of these processes may be important in embryonic
in severe disruption of dorsal structure formation. Thesedevelopment, little is known about the explicit involve-
findings suggest that regulated proteolysis is importantment of regulated proteolysis in differentiation and pat-
not only for the initiation, but also for the later establish-terning of the developing embryo.
ment of the dorsoventral axis. We discuss a model byTwo signaling pathways have been especially impli-
which a temporally initiated process of Xom degradationcated in patterning of the mesoderm during embryogen-
plays a role in establishing a sharp dorsoventral spatialesis, the Wnt signaling pathway and the BMP signaling
distribution of BMP; this in turn leads to dorsoventralpathway (Harland and Gerhart, 1997; Hoppler and Moon,
polarity in gastrulation.1998). The role of proteolysis in development was first
suggested by the findings that proteolysis of -catenin
was selectively inhibited on the future dorsal side of
Resultsthe Xenopus embryo, which marked the initial step in
dorsoventral axiation (Larabell et al., 1997; Miller et al.,
Identification of Xom as a Protein Whose Stability1999). The accumulation of-catenin at the future dorsal
Is Developmentally Regulatedside of the embryos (Larabell et al., 1997; Miller et al.,
Xenopus egg extracts have been used extensively to1999) is required for the formation of the Spemann orga-
nizer at the dorsal midline, which secretes factors that study regulation of the cell cycle (Murray, 1991). When
antagonize Wnt8 and BMP4 signaling, allowing the de- combined with screening of proteins synthesized from
velopment of neural structures and the head (De Rob- small pools of cDNAs, it has successfully identified pro-
ertis et al., 2000; Niehrs, 2001). teins that are differentially phosphorylated or degraded
at different phases of the cell cycle (Lustig et al., 1997;
McGarry and Kirschner, 1998; Stukenberg et al., 1997;3 Correspondence: marc@hms.harvard.edu
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Figure 1. Identification of Xom as a Protein Whose Stability Is Developmentally Regulated
(A) cDNAs from small pools of 50–100 plasmids were transcribed and translated in vitro in the presence of [35S]methionine as described in
the text. The 35S-labeled proteins were incubated with either pre-MBT extract (stage 7) or post-MBT extract (stage 10) for 3 hr at room
temperature; the proteins were separated on SDS-PAGE and revealed by autoradiography. As shown in pool #1, a band, later shown to be
Xom, is degraded by the pre-MBT extract but not by the post-MBT extract, as indicated by the arrow.
(B) 35S-labeled Xom was incubated with either stage 9 or stage 11 extracts for 3 hr and degradation kinetics were followed as indicated.
(C) The kinetics of Xom degradation in stage 9 and stage 11 extracts plotted on a log scale. The first-order rate constant for degradation
coefficiency was calculated using data between 30 and 180 min.
(D) mRNA (0.4 ng) encoding myc-tagged Xom was injected into two blastomeres at the two-cell stage. mRNA (0.1 ng) encoding myc-tagged
GFP was coinjected as an internal loading control. The embryos were allowed to develop until the stages indicated, and the amount of myc-
Xom was detected by Western blot as described.
(E) mRNAs encoding myc-Xom and myc-GFP were injected into either the two dorsal blastomeres or the two ventral blastomeres at the four-
cell stage. The embryos were allowed to develop until the stages indicated and the amounts of Xom and GFP were assayed as described.
(F) In vitro degradation of Xom and -catenin in stage 11 extracts.
Zou et al., 1999). More recently, both egg and later em- Xenopus blastula and neurula cDNAs, we identified two
small pools that contained proteins that were degradedbryonic extracts were used successfully to follow -cat-
enin degradation and recapitulate events of Wnt signal- more rapidly by the pre-MBT extract. After subsequent
sib selection and cloning, the gene encoding one of theing during early embryogenesis (Salic et al., 2000). To
identify the possible functions of proteolysis during early unstable proteins was identified as Xom; the other did
not correspond to known protein in the database.embryogenesis, we utilized these later embryonic ex-
tracts to identify proteins degraded in a stage-specific
manner. As the midblastula transition (MBT) marks an The Timing of Xom Degradation
At gastrula stages, the expression pattern of Xom mRNAimportant developmental stage when zygotic transcrip-
tion, cell migration, and a more complex cell cycle begin is similar to that of BMP4 and complementary to that
of the dorsal marker Xnot (Ladher et al., 1996; Onichtchouk(Newport and Kirschner, 1982), we asked whether there
were proteins that were differentially degraded before et al., 1996; Papalopulu and Kintner, 1996; Schmidt et al.,
1996). The finding that Xom protein is unstable in pre-and after that transition, as is the case for cyclin E (Howe
and Newport, 1996). As shown in Figure 1A, in the MBT extracts and stable in gastrula extracts suggested
that the Xom protein level may be under specific de-screening experiments, small pools of 50–100 cDNAs
were transcribed and translated in reticulocyte extract velopmental regulation, especially later in gastrulation
when Xom is expressed. We therefore further examinedand labeled with [35S]methionine. After incubation in pre-
(stage 7.5–8) or post- (stage 10–10.5) MBT extracts for the biochemical properties of Xom degradation during
early development both in vitro and in vivo. For the3 hr, the proteins were separated by SDS-PAGE and the
autoradiographs were compared. In 900 small pools of in vitro experiments, [35S]methionine-labeled Xom was
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incubated in embryonic extracts prepared from either To search for sequence features required for Xom
degradation, we constructed a series of deletion mu-stage 9 or 11. The degradation kinetics of Xom in differ-
ent gastrula extracts was followed on SDS-PAGE. As tants and assayed their stability in staged extracts (data
not shown). A region between amino acids 132 and 154shown in Figure 1B, Xom was degraded more rapidly in
extracts of stage 11 embryos, but remained stable in is required for the stability of Xom, as shown in Figures
2C and 2D. Xom contains two PEST domains (regionsextracts from stage 9. As shown in Figure 1C, the degra-
dation rate of Xom in stage 9 extracts was nearly zero of peptide enriched in proline, aspartic and glutamic
acids, serine, or threonine residues; Peters et al., 1998).(0.023 hr1), or a half-life of 30 hr. In stage 11 extracts,
the rate is 13 times faster (0.31 hr1), or a half-life of 2.2 The first PEST domain of Xom is located near the amino
terminus (amino acids 29–86), and when deleted, hashr. The stage-specific degradation of Xom indicates that
the proteolysis process is developmentally regulated. no effect on stability (data not shown). The sequence
132–154 of Xom corresponds to part of the second PESTThe rate of Xom degradation is decreased in embryos
that have been ventralized by UV irradiation at the one- domain (amino acids 131–172; Figure 2C), and when
deleted (Xom20), Xom is stabilized; we refer to thiscell stage (data not shown), further suggesting develop-
mental regulation. Proteolysis of Xom was also shown region as the Xom destruction motif. We showed that
Xom20 migrates as a higher molecular weight speciesto be very specific. As illustrated in Figure 1F, when
incubated with stage 11 extracts, Xom was rapidly de- after incubation with stage 11 extract (Figure 2D), indi-
cating that Xom20 was phosphorylated outside thegraded, whereas -catenin remained stable. The differ-
ential degradation of Xom and -catenin in the staged destruction motif. We went on to test the stability of
Xom20 in vivo. mRNAs encoding myc-tagged Xom20extracts again indicates that proteolysis of Xom and
-catenin are both regulated processes. or wild-type Xom were injected into either two dorsal
or two ventral blastomeres at the four-cell stage. TheFor in vivo experiments, mRNA encoding myc-tagged
Xom was injected in both blastomeres at the two-cell amount of Xom at each developmental stage was mea-
sured by Western blot. As shown in Figure 2E, the Xomstage, the embryos were cultured to the stages indi-
cated, and the amount of Xom protein was determined. protein encoded by Xom20 remains stable in both the
dorsal and ventral regions of the embryo. In contrast,Coinjected myc-tagged GFP was used as an internal
control. As shown in Figure 1D, Xom disappears rapidly wild-type Xom was cleared completely from both re-
gions before stage 11.after stage 10–10.5, while the myc-GFP shows a small
increase during the same period. Changes in Xom pro-
tein level could reflect changes in proteolysis, changes A GSK3-like Consensus Phosphorylation Site
in translational initiation, or changes in RNA level. Since in the Xom Destruction Motif Is Necessary
both myc-tagged GFP and myc-tagged Xom were in the for Xom Degradation
same vector with identical 5 and 3 sequences, the level Previous studies indicated that PEST domains may pro-
of translation initiation of both proteins should be the vide recognition sequences for phosphorylation, which
same. A single point mutation in the Xom coding region could provide regulated signals for degradation (Lanker
stabilizes Xom protein in vivo (see Figure 3D); therefore, et al., 1996; Yaglom et al., 1995). Such signals regulate
it is unlikely that the disappearance of Xom protein is due the degradation of vertebrate transcription factors, such
to RNA instability or different rates of protein synthesis. as -catenin and IKB (Chen et al., 1998; Yost et al.,
Therefore, changes in the Xom protein level during the 1996). We therefore looked for potential phosphorylation
early gastrulation stage most likely reflect changes in the sites associated with the 132–154 region of Xom that
rate of proteolysis. We also examined Xom degradation might be important for degradation. We made several
separately in dorsal and ventral hemispheres by in- constructs that converted single or several serine/threo-
jecting mRNA encoding Xom into either the two dorsal nine residues of the Xom destruction motif into alanine
or the two ventral hemispheres at the four-cell stage. (Figure 3A). The stability of Xom proteins encoded by
As shown in Figure 1E, Xom disappears from both the these mutant constructs was tested in vitro. As shown
dorsal side and the ventral side by stage 12. However in Figure 3B, when serine 140 or 144 was converted to
at stages 10 and 11, there is a slightly greater loss of alanine, Xom was partially stabilized in stage 11 ex-
Xom at the dorsal side. We observed decreased levels tracts. The degradation kinetics of wild-type Xom and
of Xom on the dorsal side at stage 10 in six out of ten the Xom S140A, S144A double mutant (Xom2sa) were
experiments; we never observed greater levels on the followed in the same set of experiments as in Figure 1C.
dorsal side. After initial rapid loss of the in vitro translated protein,
Xom2sa remained stable during the incubation ( 
0.019 hr1, or a half-life of 36 hr), while as shown inThe Mechanism of Xom Degradation
Xom is degraded by the ubiquitin/proteosome path- Figure 1C, the wild-type Xom was completely degraded
after 3 hr of incubation (  0.31 hr1, or a half-life ofway, as shown in Figure 2A. When 35S-labeled Xom was
incubated in extracts from stage 11 in the presence of 2.2 hr). Wild-type Xom is degraded about 16 times faster
than the Xom2sa mutant. The initial rapid loss of labeledHis-ubiquitin, polyubiquitinated Xom of high molecular
weight was recovered from Ni beads, indicating polyubi- protein followed by slow degradation appears to be the
property of several in vitro translated proteins in thequitination. We also examined the stability of Xom in
the presence of proteosome inhibitors. As shown in Fig- extracts, and is not Xom specific. Virtually all in vitro
translated proteins, including GFP, show partial rapidure 2B, clasto-lactocystin--lactone (an irreversible pro-
teosome inhibitor; Fenteany et al., 1995) at a concentra- degradation in extracts, a process most likely mediated
by nonspecific proteases rather than the proteosome,tion of 100 M efficiently blocked the degradation of
Xom; the minimal effective concentration in extract was since the initial loss cannot be blocked by specific pro-
teosome inhibitors (data not shown). After the first fewabout 25–50 M (data not shown).
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Figure 2. Xom Is Degraded by a Ubiquitin-Mediated Pathway
(A) 35S-labeled Xom was incubated with high-speed stage 11 extracts in the presence of his-tagged ubiquitin (HsUb) or ubiquitin (Ub).
Polyubiquitinated Xom was identified after binding to nickel beads and elution. A 2% loading control of labeled Xom protein was included.
(B) 35S-labeled Xom was incubated with stage 11 extract in the presence (	) or absence () of 100 M clasto-lactocystin--lactone (PI) for
3 hr at room temperature.
(C) Schematic structure of Xom. The amino acid sequence from 132 to 154 was deleted to create the deletion mutant of Xom, Xom20.
(D) 35S-labeled Xom and Xom20 were incubated with stage 11 extract at room temperature for 3 hr, and the proteins were analyzed by SDS-
PAGE and autoradiography.
(E) mRNA (0.4 ng) encoding either myc-tagged Xom or myc-tagged Xom20 was injected into either the two dorsal blastomeres (D) or the
two ventral blastomeres (V) at the four-cell stage. The embryos were allowed to develop to the stages indicated and the amount of remaining
Xom protein was determined by Western blotting.
minutes, the degradation of the remaining Xom and with the 20-amino acid peptide that corresponds to the
Xom destruction motif. As shown in Figure 3E, a peptideother proteins showed first-order kinetics. The stability
of Xom2sa was also tested by an in vivo assay using that contains phosphoserines at positions 140 and 144
blocked Xom degradation in a concentration-dependentthe myc-tagged form of the protein. As shown in Figure
3D, the protein level of the Xom2sa mutant remains high manner, whereas a control peptide of similar length but
unrelated sequence (from the Xom amino-terminal re-in both the dorsal and ventral sides of the embryos at
stages 11 and 12, while the wild-type Xom protein can- gion) failed to protect Xom from degradation. The impor-
tance of phosphorylation of the GSK3-like consensusnot be detected after stage 11 on either side.
The sequence DSGYES of the Xom destruction motif, phosphorylation sites in the degradation of Xom is fur-
ther illustrated in Figure 3F. When we attempted to usecontaining serines 140 and 144, resembles the GSK3
consensus phosphorylation site DSGXXS, which is im- a native unphosphorylated peptide as a control in this
in vitro degradation experiment, paradoxically, the un-portant for stability and is conserved in -catenin and
IKB and human immunodeficiency virus (HIV)-1 protein phosphorylated peptide blocked Xom degradation as
effectively as the phosphorylated peptide (Figure 3F,Vpu (Laney and Hochstrasser, 1999; Maniatis, 1999). To
further test the importance of the phosphorylation of line 2s). However, the same peptide in which serines
140 and 144 were converted into alanines was unable tothe GSK3-like consensus phosphorylation site in the
degradation of Xom, we tried to block Xom degradation block Xom degradation by the embryonic extract (Figure
Xom Proteolysis Mediates Dorsoventral Patterning
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Figure 3. A GSK3-like Consensus Phosphorylation Site Is Important for Xom Degradation
(A) Schematic presentation of serine/threonine-to-alanine mutations of the Xom destruction motif.
(B) In vitro degradation of Xom mutants which contain either single or double serine/threonine to alanine mutations at the indicated positions.
(C) The degradation kinetics of Xom2sa mutant in stage 11 extracts. Data for wild-type control were reproduced from Figure 1C. To calculate
the first-order rate constant, data from 30 to 180 min were used. The amount of protein is plotted on a log scale.
(D) In vivo stability of Xom2sa and wild-type Xom at different developmental stages.
(E) [35S]methionine-labeled Xom was incubated with stage 11 extract in the presence of a synthetic peptide corresponding to the Xom
destruction motif that contains double phosphoserines at positions 140 and 144 (PEST-2p), or a control peptide of similar length of the Xom
amino-terminal sequence. After 3 hr of incubation at room temperature, the amount of Xom proteins remaining was determined.
(F) In vitro degradation of [35S]methionine-labeled Xom in the presence of 10 M synthetic peptide corresponding to the Xom destruction
motif, which contains either two serines (2s), two phosphoserines (2p), or two alanines (2a) at positions 140 and 144.
(G) [35S]methionine-labeled Xom was incubated with stage 11 extract in the presence (	) or absence () of lithium for 3 hr at room temperature.
The effect of lithium on Xom degradation was revealed by SDS-PAGE and autoradiography.
3F, line 2a). These findings suggest that the embryonic tested the stability of Xom in embryonic extracts de-
pleted of GSK3. GSK3 was depleted by more than 95%extracts had an enzymatic activity that could phosphor-
ylate serines at positions 140 and 144 in the peptide. by beads coupled to GSK3 binding protein (Salic et
Such an activity would be unable to phosphorylate the al., 2000). Yet under these circumstances, Xom was
alanine mutants. The competition between Xom and the degraded as efficiently as in undepleted extracts (data
native peptide for the kinase in the extracts and phos- not shown). Therefore, we believe that lithium must
phorylation of the destruction motif of the native peptide block Xom degradation by inhibiting a kinase other than
by the embryonic extracts may account for the blocking GSK3.
of Xom degradation by the native peptide but not the
nonphosphorylatable peptide.
Phosphorylation of the GSK3-like Consensus
Phosphorylation Site of the Xom Destruction MotifXom Degradation Is Regulated by the GSK3-
Serves as a Signal for Xom UbiquitinationIndependent Pathway
To ask whether there was a direct link between XomWe first tested the possible involvement of GSK3 in
ubiquitination and phosphorylation of the Xom GSK3-the regulation of Xom degradation. Xom is stabilized in
like consensus site, we measured ubiquitination in vitro,extracts that contain 30 mM lithium, a rather nonspecific
using either the wild-type Xom or the mutant Xom2sa.GSK3 inhibitor (Klein and Melton, 1996), as shown in
Figure 3G. To focus more specifically on GSK3, we As shown in Figure 4, after 1 hr of incubation with stage
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was found to bind to the motif (Figure 5B), suggesting
the binding of Skp1 to the Xom destruction motif is most
likely mediated by other proteins, notably the F box
proteins, which function as substrate receptors for the
SCF complex (Skowyra et al., 1997). To search for the
F box proteins that might mediate the binding of Skp1
to the destruction motif of Xom, we incubated [35S]methi-
onine-labeled F box proteins of mouse and human origin
with affinity beads containing either the phosphorylated
Xom destruction motif or the nonphosphorylated Xom
destruction motif. As shown in Figure 5C, the human
-TRCP 1a and 1b bound specifically to the phosphory-
lated destruction motif of Xom. The association of hu-
man -TRCP to the Xom destruction motif is F box
independent since the F box-deleted mutant of human
-TRCP 1a (-TRCP1aF) also binds to the Xom de-
struction motif (although not as strongly as full-length
-TRCP). The binding of human -TRCP to the phos-
phorylated Xom destruction motif is probably specific,
Figure 4. Ubiquitination of Xom and Xom2sa since other F box proteins, such as hFBW5, mFBX5,
and mFBX8, did not bind to the Xom destruction motif35S-labeled Xom or Xom2sa were incubated with high-speed stage
11 extract in the presence of his-tagged ubiquitin (HsUb). Polyubi- under the same conditions (Figure 5C).
quitinated Xom was identified after binding to nickel beads and
elution. A 2% loading control of labeled Xom or Xom2sa protein
-TRCP Controls Xom Abundance In Vivo
was included.
To further investigate the involvement of SCF--TRCP
in the degradation of Xom, we assayed the effect of
h-TRCP1aF (which may function as a dominant nega-11 extracts, polyubiquitinated Xom containing His-
tive) on the stability of Xom during early gastrulation.tagged ubiquitin was readily detectable from the eluate
As shown in Figure 5D, when 0.4 ng mRNA encodingof Ni beads. By contrast, a lower level of polyubiquiti-
-TRCP1aF was coinjected with 0.4 ng mRNA encodingnated species was formed under the same conditions
myc-tagged Xom into both blastomeres at the two-cellwhen Xom2sa was used as a substrate for the ubiquiti-
stage, the level of Xom protein was increased 5-fold duringnation assay. This experiment suggests that the phos-
gastrulation (stage 10). The effect of -TRCP1aF onphorylation of the Xom GSK3-like consensus motif is
Xom degradation is similar to its effect on -cateninrequired for ubiquitination of the protein.
degradation (Liu et al., 1999). In contrast to the blocking
of Xom degradation by the -TRCP1aF, expression ofSCF--TRCP Ubiquitin Ligase Associates
-TRCP1a at low concentration increased Xom degra-Specifically with the Phosphorylated
dation and lowered the level of Xom. The effect ofXom Destruction Motif
-TRCP on the Xom protein level could either be directThe SCF--TRCP complex mediates phosphorylation-
or indirect. However, since -TRCP binds directly to thedependent degradation of several important molecules
phosphorylated destruction motif of Xom, it most likelysuch as -catenin and IKB (Liu et al., 1999; Yaron et
modulates the level of Xom protein during development.al., 1998). Recently, SCF--TRCP was found to bind to
the phosphorylated destruction motif of -catenin and
IKB, which contains phosphorylated serine in a GSK3 Nondegradable Xom Is More Active Than Wild-Type
Xom in Suppressing the Transcriptional Activationconsensus sequence (Winston et al., 1999). To find
whether the SCF complex is associated with the Xom of the Goosecoid Promoter by Activin
Previous studies showed that Xom binds to thedestruction motif, short peptides of 20 amino acids cor-
responding to the Xom destruction motif were synthe- Goosecoid promoter and suppresses its transcriptional
activation by activin (Trindade et al., 1999). To determinesized in either a doubly phosphorylated form (at serines
140 and 144) or a nonphosphorylated form and coupled whether the nondegradable mutants of Xom also inhibit
transcriptional activation by activin, a reporter plasmidto agarose beads. The peptide beads were incubated
with stage 9.5 and 10.5 extracts. After extensive wash- containing the Goosecoid promoter of 1500 base pairs
fused to luciferase was coinjected with mRNAs encod-ing, proteins associated with the beads were eluted with
sample buffer, and the presence of the SCF complex ing either wild-type Xom or nondegradable Xom into
two blastomeres at the two-cell stage, along with activinwas detected by anti-Skp1 immunoblotting. As shown
in Figure 5A, Skp1 was readily detected from eluates mRNA. After culturing the embryos to stage 10–10.5,
the activity of the Goosecoid promoter was measuredassociated with the phosphorylated Xom destruction
motif in both stage 9.5 and 10.5 extracts, but was not by a luciferase assay (Watabe et al., 1995). Embryos
injected with the reporter and activin mRNA but not Xomdetectable from eluates associated with the nonphos-
phorylated Xom destruction motif. The binding of Skp1 served as a control. As shown in Figure 6A, both wild-
type Xom and the nondegradable Xom inhibit Goose-to the phosphorylated Xom motif appears to be indirect.
When [35S]methionine-labeled Skp1 was incubated with coid activation by 80% at an RNA amount of 500 pg.
However, below 50 pg, wild-type Xom does not blockthe phosphorylated destruction motif of Xom, no Skp1
Xom Proteolysis Mediates Dorsoventral Patterning
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Figure 5. SCF--TRCP Binds to the Xom Destruction Motif and Modulates Xom Protein Level In Vivo
(A) Agarose beads containing either the 140, 144 double phosphoserine Xom destruction motif (P), or the wild-type Xom destruction motif
(C) were incubated with diluted embryonic stage 9.5 and 10.5 extracts at 4
C for 4 hr. After extensive washing, bound proteins were eluted
with sample buffer and applied to SDS-PAGE and subjected to Western blotting using an antibody to Skp1.
(B) 35S-labeled Skp1 was incubated with peptide beads as in (A).
(C) [35S]methionine-labeled -TRCP 1a, 1b, and 1aF (F box-deleted mutant of 1a) and control F box proteins were mixed with the affinity
beads as described above. Bound materials were revealed by SDS-PAGE and autoradiography. I: 10% of input control.
(D) mRNA (0.4 ng) encoding myc-Xom was injected into each blastomere at the two-cell stage in either the presence or absence of 0.4 ng of
mRNA encoding -TRCP1aF. The embryos were allowed to develop until stage 10 and the amount of Xom was determined by immunoblot
using anti-myc antibody as described.
(E) mRNA (2 ng) encoding myc-Xom was coinjected with 0.2 ng mRNA encoding -TRCP. The embryos were allowed to develop until stage
10 and the amount of Xom was determined as described above.
the Goosecoid promoter, while the nondegradable Xom tion during embryogenesis. Although overexpression of
wild-type Xom in dorsal blastomeres also resulted in(Xom2sa) shows inhibition down to 5 pg.
head truncation in some embryos, the concentration
requirement for wild-type Xom to achieve such a pheno-
Ectopic Expression of Nondegradable Xom at the
type is about 10–20 times that of nondegradable Xom,
Dorsal Side of Embryos Results in an Enhanced
as shown in Figure 6B. The increased potency of nonde-
Ventralized Phenotype during Embryogenesis
gradable Xom in causing head truncation is consistent
BMP4, a strong ventralizing factor (Graff, 1997; Graff et
with its increased potency in suppressing transcription
al., 1994), exerts its effect in part by inhibiting the re-
activation of the Goosecoid promoter by activin. More-
sponse to dorsal mesoderm-inducing factors such as
over, the effect of nondegradable Xom on dorsal devel-
activin. Xom was proposed as one of the mediators of
opment proved to be spatially restricted. As shown in
the BMP4 effect. The observation that Xom is an unsta-
Figure 6D, when RNA (0.4 ng) encoding Xom20 was
ble protein indicates that proteolysis may serve to limit
injected into two ventral blastomeres at the four-cell
the repression by Xom on dorsal-specific promoters
stage, there was little effect.
during early gastrulation. To test the importance of this
mechanism, RNA (0.4 ng) encoding the stable Xom20
or wild-type Xom was injected into the two dorsal blasto- Discussion
meres at the four-cell stage. The embryos were allowed
to develop to tailbud stage. As shown in Figure 6C, Although protein degradation had been postulated for
more than 50 years to play a central role in overall proteinexpression of the Xom20 results in severe head trunca-
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Figure 6. Nondegradable Xom Is More Potent Than Wild-Type Xom in Blocking Goosecoid Promoter Activation and in Ventralizing Embryos
(A) mRNA encoding either wild-type Xom or Xom2sa was injected into both blastomeres at the two-cell stage together with activin RNA (50
pg) and a Goosecoid-luciferase reporter plasmid (100 pg). The embryos were cultured to stage 10.5 and the level of luciferase activity was
measured as described.
(B) mRNA encoding Xom or Xom20 was injected into both dorsal blastomeres at the four-cell stage. The embryos were cultivated to tailbud
stage and the effect of the ectopic expression of nondegradable Xom on development was revealed. The ordinate is a scale of dorsoanterior
index (DAI) reflecting the extent of dorsal development, with 5 being a normal embryo, 2 being microcephalic, and 0 being completely
ventralized (Kao and Elinson, 1988).
(C) Embryos at the equivalent of tailbud stage, after being injected with 0.4 ng Xom20 RNA into both dorsal blastomeres at the four-cell
stage.
(D) mRNA (0.4 ng) encoding Xom20 was injected into either the two dorsal blastomeres (left embryo) or the two ventral blastomeres (right
embryo) at the four-cell stage. The embryos were allowed to develop until the tailbud stage, and the effect of ectopic expression of the
nondegradable Xom was revealed.
metabolism (Kirschner, 1999), it is only rather recently Identification of Xom as a Developmental Gene
Regulated by Proteolysisthat its importance as a key regulator of the cell cycle,
inflammation, and transcription has been described. We initially targeted our screen to identify genes that
are differentially degraded before and after the onsetFundamental to this understanding has been the identifi-
cation of key substrates of these processes, such as of midblastula transition (MBT). Of more than 50,000
proteins screened (representing an unknown numberG1 and M phase cyclins as well as p53, IKB, GCN4, and
-catenin, among others. In all these cases, proteolytic of different genes), only two were identified clearly to
show stage-specific degradation. One was isolated andpathways occupy central control points. We have pre-
viously shown that in vitro expression cloning using shown by DNA sequencing to be identical to Xom. The
other did not correspond to any known protein in thesmall pools of cDNAs can be used to identify novel
targets of regulated degradation in the cell cycle, such database. The significance of Xom proteolysis in the pre-
MBT extract is not clear, since Xom is not expressed.as geminin (McGarry and Kirschner, 1998) and securin
(Zou et al., 1999). We have applied this screening ap- However, the differential stability of Xom pre- and post-
MBT led us to investigate Xom stability throughout gas-proach to ask whether there is evidence for stage-spe-
cific protein degradation in early embryonic develop- trulation. We found that Xom is stable during early gas-
trulation but is degraded at late gastrulation, indicatingment, and whether it plays a central regulatory role in
development. that proteolysis plays a regulatory role.
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Xom Is Degraded by the Ubiquitin-Mediated
Pathway during Early Gastrulation
High molecular weight species of Xom conjugated to
ubiquitin were found in in vitro assays, and degradation
of Xom was blocked by 26S proteosome inhibitors, indi-
cating that Xom is degraded by the ubiquitin-proteo-
some pathway. We found that part of the second PEST
domain of Xom is crucial to conferring instability to the
Xom protein. This domain contains a GSK3-like consen-
sus phosphorylation sequence, DSGXXS (Yost et al.,
1996), which has been shown to be important in the
degradation of -catenin, IKB, and HIV-1 protein Vpu/
CD4 (Laney and Hochstrasser, 1999; Maniatis, 1999).
Mutagenesis studies and the peptide blocking experi-
ments showed that the phosphorylation status of the
two serines in the GSK3-like consensus site is important
for the degradation of Xom, and that the phosphorylation
Figure 7. The Role of Xom Proteolysis in Dorsoventral Pattern For-of the GSK3-like consensus sequence provides a signal
mationfor Xom ubiquitination and subsequent degradation.
In this model, the temporal degradation of Xom throughout theSince both serines are shown to be important, a question
embryo is used to convert a bias in BMP distribution into an all orremains whether these sites are phosphorylated simul-
none process leading to distinct dorsoventral patterning. We as-
taneously or sequentially, as in the case of sic 1 degrada- sume that there will be other features of the circuit that also contrib-
tion (Deshaies and Ferrell, 2001; Nash et al., 2001). In ute but are not shown here. The elements of the circuit are very
searching for the kinases involved in Xom degradation, simple and are portrayed in four different states: dorsal at pregas-
trula (stage 9.5), dorsal at late gastrula (stage 11), ventral at pregas-we have shown that Xom degradation is not triggered
trula (stage 9.5), and ventral at late gastrula (stage 11). The circuitby GSK3. Interestingly, of the three proteins that bear
involves an activation of Xom by BMP and activation of BMP byGSK3-like consensus phosphorylation sites, only-caten-
Xom. Although this is transcriptional, the names signify protein activ-
in is actively phosphorylated by GSK3; IKB is phos- ities. A second feature of the circuit is the inhibition of dorsal genes
phorylated by the IKB kinase complex (Zandi et al., 1998) by Xom (transcriptional) and the inhibition of BMP activity by dorsal
and the HIV-1 protein Vpu is phosphorylated by casein genes, such as chordin. At stage 9.5, there is a small excess of
BMP on the ventral side, so that the BMP-Xom autoactivated circuitkinase II (Paul and Jabbar, 1997; Schubert et al., 1994).
is shown in larger and bolder letters than the corresponding circuitThe ubiquitin ligase involved in Xom ubiquitination is
on the dorsal side. This is due to the expression of BMP inhibitorslikely to be -TRCP, the E3 complex that mediates the
on the dorsal side. By stage 11, Xom is degraded in both regions,
degradation of -catenin and IKB (Maniatis, 1999). eliminating the Xom-BMP autoactivating circuit. In the absence of
-TRCP binds to the phosphorylated destruction motif dorsal genes on the ventral side, BMP activity remains high. Without
of Xom, as it does to the phosphorylated destruction the Xom-BMP autoactivating circuit, BMP activity declines to zero
on the dorsal side. The result is large quantitative differences in BMPmotifs of -catenin and IKB. In support of this conclu-
level and activity and dorsal gene expression in the two regions.sion, the F box-deleted mutant of -TRCP blocks Xom
degradation in vivo, and low concentrations of wild-type
-TRCP increase the rate of degradation of Xom in vivo. feel contributes critically to the segregation of BMP sig-
However, we cannot rule out the possibility that an en- nals to the ventral side. Nondegradable Xom is roughly
dogenous F box protein similar to but distinct from 20 times more active than wild-type Xom in inhibiting
-TRCP may be involved in the Xom degradation. the transcriptional activation of the Goosecoid promoter
-TRCP is involved in several important degradation by activin and in blocking dorsoanterior development.
processes, such as -catenin and IKB in vertebrates This effect of stable Xom suggests that proteolysis of
(Kitagawa et al., 1999; Yaron et al., 1998), Cubitus inter- Xom is a required regulatory event terminating the inhibi-
ruptus (Ci) in Drosophila (Jiang and Struhl, 1998), as well tion of the expression of dorsal-specific genes on the
as the human HIV-1 protein Vpu/CD4 (Maniatis, 1999; dorsal side. Just after the midblastula transition, BMP4
Margottin et al., 1998). Given these diverse targets, a key and Xom are expressed throughout the embryo. Tran-
question is what gives specificity to these processes. In scription of Xom is enhanced by BMP4. Xom expression
the case of -catenin, local inhibition of GSK3 activity by in turn reinforces the expression of BMP4 in a potential
the protein disheveled controls -catenin degradation, autoactivating feedback loop that would maintain high
presumably in a compartmentalized way; it is intriguing BMP4 levels and block development of dorsal structures
to think that proximity effects may also play a role in (Ladher et al., 1996; Onichtchouk et al., 1996). Some-
Xom degradation. thing, therefore, is needed to break this loop.
As shown in Figure 7, our data suggest that regulated
proteolysis of Xom at a specific time is essential forRegulated Proteolysis and Dorsoventral Pattern
Formation in Early Gastrulation generating a dorsoventral pattern in the mesoderm dur-
ing gastrulation. The proteolysis of Xom shows preciseThe patterning of early gastrula mesoderm sets aside a
BMP-free zone on the dorsal side. This has been ex- temporal regulation. At stage 10, there seems to be a
slight bias causing more rapid loss of Xom on the dorsalplained by the expression of BMP inhibitors secreted
by the Spemann organizer. We report here on another relative to the ventral side (Figures 1D and 3D), but this
in itself is probably not very important and may not beimportant process in dorsoventral patterning, which we
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reactions of small pools of cDNAs using a Promega TNT kit (perfound in all embryos. What is clear and reproducible is
the manufacturer’s instructions). For a typical reaction, 0.5 l ofthe precise loss of Xom in the late gastrula. How does a
[35S]methionine-labeled proteins were incubated with 4.5 l ofsignal that is not spatially localized contribute to spatial
staged extracts supplemented with energy mix, ubiquitin, and cyclo-
patterning? The high level of BMP4 on the ventral side heximide at 22
C for 3 hr. Reactions were stopped by the addition
must be self-maintaining in the absence of Xom. On the of 2 sample buffer, and samples were analyzed by SDS-PAGE
followed by autoradiography.dorsal side, in the presence of BMP inhibitors, BMP4 is
not self-maintaining when Xom is degraded. It is for this
reason that Xom degradation has consequences on the Ubiquitination Assay
dorsal side but no consequences on the ventral side. In Xom was labeled with [35S]methionine in a TNT reaction. [35S]methio-
nine-labeled proteins (2 l) were incubated with 20 l high-speedthis system, dorsoventral asymmetry in the mesoderm
extract supplemented with either regular ubiquitin or his6-taggedseems to be highly poised, set to collapse into either of
ubiquitin (0.2 mg/ml) together with energy mix, protease inhibitors,two states: dorsal with low BMP4 and ventral with high
and cycloheximide at room temperature for 1 hr. Following the reac-
BMP4; the reaction pathway will not allow intermediate tion, the mixture was diluted 10-fold with PBS and 1% Tween-20
states. As shown by Onichtchouk et al. (1996), this au- (pH 7.3), and 5 l of Ni beads was added to the reaction. Binding
toactivation loop can be easily broken by expressing a was performed at 4
C for 2 hr. Bound materials were spun down
briefly. After four washes with 0.5 ml of PBS, 1% Tween 20, thedominant-negative form of Xom. Physiologically, this
bound proteins were eluted with sample buffer and analyzed byloop is probably broken by secreted inhibitors of BMP4,
SDS-PAGE and autoradiography.which creates the initial dorsoventral bias, followed by
the degradation of Xom. Smurf1 may also contribute to
In Vivo Xom Stability Assaysetting the dorsoventral threshold of BMP4 autoactiva-
mRNA (0.4 ng) encoding myc-tagged Xom or Xom mutants wastion. Together with recent findings that smurf1 medi-
injected into two blastomeres at the two- to four-cell stage together
ates degradation of Smad1 and reduces BMP signaling with an internal marker of 0.1 ng myc-tagged GFP. For a typical
(Podos et al., 2001; Zhu et al., 1999), we propose that reaction, five embryos were cultured to different developmental
temporally regulated proteolysis (and not necessarily stages and collected in 1.5 ml Eppendorf tubes. The embryos were
submerged in 50 l XB and homogenized by pipetting up and downspatially regulated proteolysis) may play a central regu-
several times. The cytoplasm was cleared by brief spinning in thelatory role in embryonic patterning, converting a slight
microcentrifuge at top speed; 5 l of the clear extract was mixedbias in BMP signaling into an all or none effect. There
with the same volume of 2 sample buffer and subjected to SDS-
are two important unanswered questions related to the PAGE. The amount of Xom or Xom mutants was measured by West-
regulated degradation of Xom: how is Xom transiently ern blot with antibodies to myc.
stabilized in the early gastrulation stage and what turns
on global Xom degradation later in gastrulation? An- Plasmids and Mutant Construction
swering these questions will be required to understand Plasmids encoding F box proteins are generous gifts of Dr. Michele
the complex process of dorsoventral pattern formation Pagano of the New York University Medical Center and Dr. Wade
Harper of Baylor Medical College. Reagents for the luciferase assayduring early development.
were contributed by Dr. Malcolm Whitman of Harvard Medical
School. Deletion mutations of Xom were made by PCR-based muta-Experimental Procedures
genesis. Point mutations were created with the Stratagene Quick-
Change mutagenesis kit, according to the manufacturer’s instruc-Preparation of Xenopus Embryos and Embryonic Extracts
tions. Primer sequences for mutagenesis will be provided uponXenopus embryos were obtained by in vitro fertilization. Embryos
request. All cDNAs were cloned in the CS2 plasmid and tested bywere cultured to specific stages as described (Kay and Peng, 1991)
sequencing and in vitro translation assay.and staged according to the method of Nieuwkoop and Faber (1994).
Embryonic extracts were prepared essentially as described, with
some modifications (Salic et al., 2000). Embryos of specific develop-
Luciferase Assay
mental stages were collected and dejellied. After three washes with
For the luciferase assay, both blastomeres at the two-cell stage
0.1 Marc’s Modified Ringer’s (MMR) solution, the embryos were
were injected with 10 nl of RNA encoding Xom or Xom mutants,
washed once in extraction buffer (XB; 100 mM KCl, 1 mM MgCl2, together with 50 pg of activin RNA and 100 pg reporter plasmid.
0.1 mM CaCl2) with 100 mM sucrose and packed in 1.5 ml Eppendorf The embryos were cultured to stage 10–10.5. Five embryos were
tubes by spinning at 300 g for 30 s. The embryos were then crushed
collected and lysed in 50l lysis buffer (Promega). After being micro-
at 21,000 g for 5 min. The cytoplasmic layer was removed and
centrifuged at top speed for 10 min at room temperature, luciferase
supplemented with 2 l cytochalasin B (10 mg/ml in DMSO) and
activity was determined in 5 l of the supernatant, according to
1 l of protease inhibitors (10 mg/ml of leupeptin, chemostatin, and
the manufacturer’s instructions and quantified with a scintillation
pepstain in DMSO). The crude extracts were cleared by spinning at
counter.
21,000 g for 5 min twice. Energy mix (150 mM creatine phosphate,
20 mM ATP, 2 mM EDTA [pH 7.7], 20 mM MgCl2) and ubiquitin (15
mg/ml) were added after the final spin, and aliquots of the staged In Vitro Binding Assay
Twenty amino acid peptides corresponding to the Xom destructionextracts were quickly frozen in liquid nitrogen and kept in 80
C
for further use. High-speed extracts were prepared as described motif (residues 131–150) were synthesized in both wild-type form
and with serines 140 and 144 doubly phosphorylated (with pre-(King et al., 1995) and used in the in vitro ubiquitination assay.
Microinjection of RNA and DNA was carried out in 0.1 MMR con- made phosphoserine), and were coupled to agarose beads at 1 mg/
ml (Genemed). To test the binding of the SCF/Skp1 complex withtaining 4% ficoll. After injection, embryos were transferred to a
medium of 0.1 MMR and cultured to specific stages at a tempera- the destruction motif, staged extracts were diluted five times with
XB, 0.1% NP-40, and protease inhibitors, and 10 l of either phos-ture below 19
C.
phorylated peptide beads or control nonphosphorylated beads was
added to 200 l of the diluted extracts. After incubation at 4
C forIn Vitro Degradation Assay and Developmental Screen
Detailed methods for the in vitro degradation assay and screening 4 hr, beads were washed three times with binding buffer, and bound
proteins were eluted with 50 l sample buffer; 10 l of the samplesof small pools of Xenopus cDNA libraries have been described (Lus-
tig et al., 1997; Salic et al., 2000). In brief, [35S]methionine-labeled was subjected to SDS-PAGE and analyzed by Western blot using
a monoclonal antibody to Skp1 and ECL reagent (Amersham).proteins were obtained by transcription and translation coupling
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